03/03/2013 11:54:00

EADS CEO: Chances to Exceed Official Profitability Target-Report

The chief executive officer of European Aeronautic Defence & Space Co. (EAD.FR) sees chances for a higher than officially targeted return on sales, according to a preview in Focus magazine on Sunday.

In the financial year 2012, EADS posted earnings before interest and taxes ratio of 5.3% of revenues, recorded before one-off items, according to EADS' 2012 annual results. Officially, EADS is seeking to boost this 5.3% to 10% by 2015, the magazine said.

"That's not necessarily the peak," CEO Thomas Enders said, seeing "very good potential" especially in the commercial aircraft business, the magazine reported.

EADS units are still far from the 10% return target that requires fierce cost control, the magazine said, adding that serious problems may not appear especially during the development and production of new jets if the company want to earn more in the future.

Magazine website: www.focus.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

(END) Dow Jones Newswires

March 03, 2013 06:54 ET (11:54 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Nogle brugere (Pav3 og ebdrups især) har skrevet lidt om FDA's afvisning af Envarsus. Jeg vil gerne ..
14 Nov
  Lad mig starte med en meget vigtig pointe: Når man ejer en aktie, ejer man en andel af en virksomh..
16 Nov
Forord Jernmalmens pris er faldet dramatisk siden toppen i år 2011. Med inspirerende tanker fra brug..
18 Nov
Normal 0 21 false false false DA X-NONE X-NONE ..
19 Nov
  Her følger mine tanker efter Bioporto Q3 regnskab samt efterfølgende investor præsentation   Omsæt..
14 Nov
Jeg får tit spørgsmålet, "hvad er den bedste indikation på, at et selskab og dets aktiekurs har en s..
19 Nov
stop nu det børnehave pjat i er jo ikke en døjt bedre selv. Pokerchamp har ændret fint stil fra tidl..
18 Nov
Opsang til EI   Det er efterhånden en børnehave i mange af trådene herinde, og jeg kan ikke forstå a..
18 Nov
Nå, GEN fik ikke sneget sig ind i late-breaking abstracts på en Gilead sponsoreret idelalisib+ofatum..
14 Nov
Veloxisme ?   Når jeg følger Veloxis-debatten, er det lige før jeg tænker, at vi her på EI har opfun..

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
Leipurin Plc applies for listing on the NASDAQ OMX Helsinki Ltd
Sanofi : Sanofi Outlines Next Wave of Innovative Medicines and Vaccines
New CEOs in Grameenphone and Uninor
Collabrium Japan Acquisition Corporation Announces Nasdaq Hearings Panel Decision to Continue Listing of Company's Securities
Aspo Oyj: Invitation to the Extraordinary Shareholders' Meeting
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
20 November 2014 20:31:17
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20141120.1 - EUROWEB6 - 2014-11-20 21:31:17 - 2014-11-20 20:31:17 - 1000 - Website: OKAY